2-[4-amino-N-(2-hydroxyethyl)-3-nitroanilino]ethanol,hydrochloride

We are 2-[4-amino-N-(2-hydroxyethyl)-3-nitroanilino]ethanol,hydrochloride CAS:94158-13-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:
2-[4-amino-N-(2-hydroxyethyl)-3-nitroanilino]ethanol,hydrochloride
CAS.NO:94158-13-1
Synonyms:HC Red no. 13; 1-amino-2-nitro-4-bis-(2'-hydroxyethyl)aminobenzene hydrochloride; 2,2'-((4-Amino-3-nitrophenyl)azanediyl)diethanol hydrochloride; 2,2'-[(4-Amino-3-nitrophenyl)imino]bisethanol hydrochloride;
Molecular Formula:C10H16ClN3O4
Molecular Weight:277.70500
 
Physical and Chemical Properties:
Boiling point:515.9oC;
Flash point:265.8oC;
 
Specification:
Appearance:Yellow crystalline powder
Purity(HPLC):≥99.0%
Ash:≤1.0%
Loss on drying:≤1.0%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate
 

2-[4-amino-N-(2-hydroxyethyl)-3-nitroanilino]ethanol,hydrochloride


Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.1-Benzhydrylazetidin-3-amine CAS:40432-52-8 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.N- (2-amino-4,5,6,7-tetrahidrobenzo [d] tiazol-6-il) acetamida bromhidrato CAS:104617-50-7 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.2-nitro-p-toluidine CAS:89-62-3 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.

Related Products
Product Name
N2-(1-Oxohexadecyl)-L-lysyl-L-valyl-(2S)-2,4-diaminobutanoyl-L-threonine bis(trifluoroacetate) (salt) View Details
2-Amino-3,5-dichloropyridine View Details
2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile View Details
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride manufacturer 4-(Difluoromethoxy)aniline manufacturer 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate manufacturer 3,5-DI-O-(P-TOLUYL)-2-DEOXY-D-RIBOFURANOSYL CHLORIDE manufacturer 1-bromo-4-(4-bromo-3-methylphenyl)-2-methylbenzene manufacturer